Kaya Holdings Past Earnings Performance
Past criteria checks 2/6
Kaya Holdings has been growing earnings at an average annual rate of 3.4%, while the Pharmaceuticals industry saw earnings declining at 0.8% annually. Revenues have been declining at an average rate of 18.8% per year.
Key information
3.4%
Earnings growth rate
1.6%
EPS growth rate
Pharmaceuticals Industry Growth | 6.0% |
Revenue growth rate | -18.8% |
Return on equity | n/a |
Net Margin | 820.0% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Kaya Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 0 | 2 | 1 | 0 |
30 Sep 23 | 0 | 3 | 2 | 0 |
30 Jun 23 | 0 | -6 | 2 | 0 |
31 Mar 23 | 1 | -2 | 2 | 0 |
31 Dec 22 | 1 | -4 | 2 | 0 |
30 Sep 22 | 1 | -3 | 2 | 0 |
30 Jun 22 | 1 | 8 | 2 | 0 |
31 Mar 22 | 1 | 14 | 2 | 0 |
31 Dec 21 | 1 | 10 | 2 | 0 |
30 Sep 21 | 1 | 11 | 2 | 0 |
30 Jun 21 | 1 | -6 | 2 | 0 |
31 Mar 21 | 1 | -17 | 2 | 0 |
31 Dec 20 | 1 | -12 | 2 | 0 |
30 Sep 20 | 1 | -17 | 3 | 0 |
30 Jun 20 | 1 | -2 | 3 | 0 |
31 Mar 20 | 1 | 3 | 3 | 0 |
31 Dec 19 | 1 | 8 | 3 | 0 |
30 Sep 19 | 1 | 2 | 2 | 0 |
30 Jun 19 | 1 | 2 | 2 | 0 |
31 Mar 19 | 1 | -4 | 2 | 0 |
31 Dec 18 | 1 | 5 | 4 | 0 |
30 Sep 18 | 1 | -6 | 4 | 0 |
30 Jun 18 | 1 | -7 | 3 | 0 |
31 Mar 18 | 1 | 1 | 3 | 0 |
31 Dec 17 | 1 | -15 | 3 | 0 |
30 Sep 17 | 1 | -16 | 2 | 0 |
30 Jun 17 | 1 | -17 | 2 | 0 |
31 Mar 17 | 1 | -23 | 2 | 0 |
31 Dec 16 | 1 | -20 | 2 | 0 |
30 Sep 16 | 1 | -1 | 2 | 0 |
30 Jun 16 | 1 | -1 | 2 | 0 |
31 Mar 16 | 1 | -2 | 1 | 0 |
31 Dec 15 | 0 | -3 | 2 | 0 |
30 Sep 15 | 0 | -4 | 1 | 0 |
30 Jun 15 | 0 | -4 | 1 | 0 |
31 Mar 15 | 0 | -3 | 2 | 0 |
31 Dec 14 | 0 | -2 | 1 | 0 |
30 Sep 14 | 0 | -1 | 1 | 0 |
30 Jun 14 | 0 | -1 | 1 | 0 |
31 Mar 14 | 0 | 0 | 0 | 0 |
31 Dec 13 | 0 | 0 | 0 | 0 |
30 Sep 13 | 0 | 0 | 0 | 0 |
Quality Earnings: KAYS has a large one-off gain of $537.3K impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: KAYS became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: KAYS has become profitable over the past 5 years, growing earnings by 3.4% per year.
Accelerating Growth: KAYS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: KAYS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (3.7%).
Return on Equity
High ROE: KAYS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.